Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival

Sorafenib has been recommended as first- or second-line treatment for metastatic renal cell carcinoma (mRCC) by several guidelines. The objective of this study is to evaluate the efficacy of sorafenib monotherapy in Chinese patients with mRCC and determine the prognostic clinicopathologic factors as...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Yu, Xiaoteng, Guo, Gang, Li, Xuesong, Zhang, Cuijian, Huang, Lihua, Fang, Dong, Song, Yi, Zhang, Xu, Zhou, Liqun
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2015
Subjects:
5700
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602909/
https://ncbi.nlm.nih.gov/pubmed/26313773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001361
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items